Jan 23 Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd:
* KL KAPPA SDN TO SUBSCRIBE TO NEW SHARES & TO BUY SOME EXISITNG SHARES IN LABLINK (M) SDN FROM UNIT FOR 119.9 MILLION RGT Source text: (http://bit.ly/2n39rAZ) Further company coverage:
* LEE CHING TON BRANDELYN HAS RESIGNED AS AN EXECUTIVE DIRECTOR Source text for Eikon: Further company coverage:
TEL AVIV, Jan 23 Israeli biopharmaceutical company BioCanCell said on Tuesday it has signed a term sheet to receive a $25 million investment and it plans to go public in the United States during 2018.
* Says it issues 130 million shares at 15.36 yuan per share and raised 2 billion yuan in total via private placement
No related earnings announcements are currently scheduled within the next 7 days.